People channel feed

Fresh off $100M round, GV-backed re­al-world da­ta start­up woos Duke re­searcher as CMO

6 years ago
Startups

Mer­ck los­es its chief dig­i­tal of­fi­cer, spot­light­ing tal­ent hunt for the hottest ti­tle in Big Phar­ma

6 years ago
R&D

Eli Lil­ly vet Ker­ry Blan­chard takes the helm at one of Chi­na's top deal­mak­ers, steer­ing to­ward first ap­provals

6 years ago
China

Biotech CEO who lied about cur­ing his own paral­y­sis sen­tenced to 7 years in jail

6 years ago

Carl June on CRISPR, CAR–T and how the Viet­nam War dropped him in­to med­i­cine

6 years ago
R&D
In Focus

No­var­tis chris­tens new UK HQ in West Lon­don, kick­ing off its big in­clisir­an CV tri­al

6 years ago
R&D
Pharma

A crash­ing Wave takes out the bud­get ax to chop staff, aban­don­ing work on Duchenne MD in re­struc­tur­ing

6 years ago
R&D

Scott Got­tlieb adds one more high-pro­file board seat to the post-FDA re­sume. And it’s an­oth­er plum as­sign­ment

6 years ago

Ian Read adds a new post to his grow­ing ros­ter of post-Pfiz­er po­si­tions — and this one pays well

6 years ago
R&D

'What's he go­ing to do? He's go­ing to date his wife more!' Steve Holtz­man on Deci­bel and leav­ing biotech (again)

6 years ago

How do Amer­i­can sci­en­tists get em­broiled in Chi­na scan­dals? Mof­fitt in­ves­ti­ga­tion sheds some light

6 years ago
China

Lau­rence Reid re­turns as CEO of Deci­bel Ther­a­peu­tics — as Steve Holtz­man re­tires

6 years ago

Top Har­vard chemist caught up in FBI’s 'T­hou­sand Tal­ents' drag­net, ac­cused of ly­ing about Chi­nese con­nec­tions, pay

6 years ago
China

Eye­ing a trio of tri­al ini­ti­a­tions, Jim Wilson's gene ther­a­py start­up woos Bruce Gold­smith from Deer­field as CEO

6 years ago
Cell/Gene Tx

Mike Bloomberg joins a grow­ing cho­rus of De­mo­c­ra­t­ic pres­i­den­tial can­di­dates threat­en­ing to go af­ter drug patents

6 years ago
Pharma

Ex-No­var­tis CEO Joe Jimenez is tak­ing an­oth­er crack at open­ing a new chap­ter in his ca­reer — and that in­cludes a new board seat and a $250M start­up

6 years ago
Startups
R&D

The FTC and New York state ac­cuse Mar­tin Shkre­li of run­ning a drug mo­nop­oly. They plan to squash it — and per­ma­nent­ly ex­ile him

6 years ago
FDA+

Ku­ra co-founder heads to Asian mul­ti-na­tion­al as biotech eyes the goal posts for lead drug

6 years ago

'Y­ou be­trayed that du­ty': For­mer con­gress­man Chris Collins sen­tenced to 26 months in jail for in­sid­er trad­ing

6 years ago

Bernie Sanders goes af­ter Bio­Mar­in's shot at a record drug price, threat­en­ing to break the patent

6 years ago
Bioregnum
Pharma

Chi­na’s fourth rich­est man takes a back seat at the top drug­mak­er he built

6 years ago
China

#JPM20 ex­clu­sive: Olivi­er Brandi­court fol­lows the Big Phar­ma CEO path to pri­vate eq­ui­ty, join­ing Black­stone ahead of a mam­moth fund de­but

6 years ago
R&D

Cel­gene ex­ec jumps to head blue­bird bio ops in Eu­rope, where its $1.8M gene ther­a­py Zyn­te­glo is now avail­able

6 years ago

War­ren and Klobuchar say they can low­er drug prices with­out Con­gress’ help

6 years ago
Pharma
First page Previous page 70717273747576 Next page Last page
A service from the Financial Times